Clinical Trial Update: A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy [Phase 1]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1 pharmacokinetic study of oral deflazacort in children and adolescents with Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• EMFLAZA (deflazacort)

Snippet

Sponsor: PTC Therapeutics | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED